News
An intervention designed to emphasize management of overweight and obesity in primary care settings was associated with ...
As Healio previously reported, palopegteriparatide (Yorvipath, Ascendis Pharma), a prodrug ... among patients with chronic hypoparathyroidism. Image: Adobe Stock The trial included 82 adults ...
Johannesburg - Ascendis Health [JSE:ASC] is continuing its international growth strategy with the announcement of separate acquisitions of two major European health and care businesses for a total of ...
On Tuesday in a trading update it said it expects a major increase in earnings for for the year ended 30 June 2020. Ascendis Health announced on Tuesday that it expects its earnings to increase by up ...
Ascendis Pharma A/S (NASDAQ:ASND) is among the 12 best healthcare stocks to buy now. On June 10, Canaccord Genuity reiterated ...
23 Oct 2024 (Johannesburg Stock Exchange) Ascendis Health Limited announced that its application to transfer its listing to the General Segment of the Main Board of the Johannesburg Stock Exchange ...
All relevant comments and Ascendis Health Ltd share chat regarding the ASCJ JO share news are listed here in the ASCJ forum. View and contribute to the ASCJ share chat. Discuss Ascendis Health Ltd ...
Ascendis Pharma A/S (NASDAQ:ASND), with a market capitalization of $9.8 billion, has been garnering significant attention from analysts due to its innovative product portfolio and promising market ...
A newly developed PET radiotracer has shown the ability to produce high-quality images of real-time brain inflammation, ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results